Sequential Therapies After Osteoanabolic Treatment

2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis

NCT00191425 ·Status: COMPLETED ·Phase: PHASE4

Combined Anabolic Therapy

NCT06558188 ·Status: RECRUITING ·Phase: PHASE4

Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis

NCT01575834 ·Status: COMPLETED ·Phase: PHASE3

Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

NCT00927186 ·Status: COMPLETED ·Phase: PHASE4

Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis

NCT01674621 ·Status: COMPLETED ·Phase: PHASE2

Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women

NCT04974723 ·Status: COMPLETED

Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients

NCT06938152 ·Status: RECRUITING ·Phase: PHASE4

Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis

NCT00404820 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women

NCT01343004 ·Status: COMPLETED ·Phase: PHASE3

A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

NCT00471237 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)

NCT00092014 ·Status: COMPLETED ·Phase: PHASE3

StrAtegies For Zoledronic Acid Post-dEnosumab Discontinuation in Postmenopausal oSTeoporosis

NCT06767150 ·Status: RECRUITING ·Phase: PHASE4

Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis

NCT01535027 ·Status: COMPLETED ·Phase: PHASE4

An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women

NCT01796301 ·Status: COMPLETED ·Phase: PHASE3

Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM)

NCT00365456 ·Status: COMPLETED ·Phase: PHASE3

Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis

NCT01406613 ·Status: COMPLETED

A Dose-response Study With Strontium Malonate in Postmenopausal Women

NCT00409032 ·Status: COMPLETED ·Phase: PHASE2

Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis

NCT00035256 ·Status: COMPLETED ·Phase: PHASE4

Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)

NCT05575167 ·Status: RECRUITING

Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid

NCT00097812 ·Status: COMPLETED ·Phase: PHASE3

A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis

NCT02016716 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures

NCT06720350 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis

NCT00542425 ·Status: COMPLETED ·Phase: PHASE2

Circulating Myokine Levels and Bone Metabolism

NCT04206618 ·Status: COMPLETED

Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass

NCT01604057 ·Status: UNKNOWN ·Phase: PHASE2